NASH: Connecting the dots with patients in mind
- PMID: 33102792
- PMCID: PMC7576233
- DOI: 10.1002/edm2.109
NASH: Connecting the dots with patients in mind
Abstract
Liver patient, patient advocate and patient advocacy organization leader describe the requisite actions for connecting patients, physicians, policymakers and global leaders into a global movement to address the epidemic of nonalcoholic steatohepatitis.
© 2020 The Authors. Endocrinology, Diabetes & Metabolism published by John Wiley & Sons Ltd.
References
-
- Rinella ME. Nonalcoholic fatty liver disease: a systemic review. JAMA. 2015;313:2263‐2273. - PubMed
-
- Ipsos Group S.A . (n.d). The NASH Truth Survey 2019 (Vol. 2.0), Paris, FR: Ipsos Group S.A.
-
- Younossi ZM, Golabi P, de Avila L, et al. The global epidemiology of NAFLD and NASH in patients with type 2 diabetes: a systematic review and meta‐analysis. J Hepatol. 2019;71:793‐801. - PubMed
-
- Liver Illness Visibility Education and Research Act (2019) (USA).
Publication types
LinkOut - more resources
Full Text Sources